Sentara Norfolk General Hospital is a large academic hospital, which serves as the primary teaching institution for the adjacent Eastern Virginia Medical School.

There are 563 beds in Sentara Norfolk General Hospital.

During the past decade, Sentara Norfolk General Hospital conducted 104 clinical trials. In the 10-year time frame, 104 clinical trials started and 75 clinical trials were completed, i.e. on average, 72.1% percent of trials that started reached the finish line to date. In the past 5 years, 41 clinical trials started and 36 clinical trials were completed. i.e. 87.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sentara Norfolk General Hospital" #1 sponsor was "Abbott Medical Devices" with 27 trials, followed by "Boston Scientific Corporation" with 27 trials sponsored, "Alliance for Clinical Trials in Oncology" with 12 trials sponsored, "Medtronic Cardiac Rhythm and Heart Failure" with 12 trials sponsored and "National Cancer Institute (NCI)" with 12 trials sponsored. Other sponsors include 135 different institutions and companies that sponsored additional 92 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sentara Norfolk General Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 25 trials as a collaborator, "NRG Oncology" with 12 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 8 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator and "Eli Lilly and Company" with 4 trials as a collaborator. Other collaborators include 75 different institutions and companies that were collaborators in the rest 71 trials.

According to Clinical.Site data, the most researched conditions in "Sentara Norfolk General Hospital" are "Heart Failure" (19 trials), "Coronary Artery Disease" (13 trials), "Atrial Fibrillation" (11 trials), "Prostate Cancer" (6 trials) and "Pulmonary Arterial Hypertension" (6 trials). Many other conditions were trialed in "Sentara Norfolk General Hospital" in a lesser frequency.

Most popular intervention types in "Sentara Norfolk General Hospital" are "Device" (127 trials), "Drug" (70 trials), "Other" (34 trials), "Procedure" (21 trials) and "Radiation" (20 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Laboratory Biomarker Analysis" (7 trials), "Intensity-Modulated Radiation Therapy" (6 trials), "Quality-of-Life Assessment" (5 trials) and "3-Dimensional Conformal Radiation Therapy" (3 trials). Other intervention names were less common.

The vast majority of trials in "Sentara Norfolk General Hospital" are 210 trials for "All" genders, 10 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "Sentara Norfolk General Hospital". undefined are not yet recruiting, 42 are recruiting, 50 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 111 completed trials in Sentara Norfolk General Hospital, 2 suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in Sentara Norfolk General Hospital, 4 "Phase 1" clinical trials were conducted, 28 "Phase 2" clinical trials and 62 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 17 trials, and there were also 93 trials that are defined as “Not Applicable".

Sentara Norfolk General Hospital has several departments that took part in Clinical trials: "Sentara Cardiovascular Research Institute" - 38 trials, "Sentara Cancer Institute at Sentara CarePlex Hospital" - 22 trials, "Sentara Cancer Institute at Sentara Norfolk General Hospital" - 20 trials, "Sentara Neurology Specialists" - 18 trials, "Sentara Heart Hospital" - 18 trials, "Urology of Virginia - Sentara Medical Group" - 5 trials, "Sentara Cardiovascular" - 3 trials, "Surgical Oncology Associates" - 3 trials, "Sentara Norfolk General Emergency Department" - 2 trials, "Sentara Ambulatory Care Center" - 2 trials